Ami Kanai
Papers
1
Total Citations
2
H-Index
1
About
Dr. Ami Kanai is a dedicated clinician-researcher specializing in hereditary cancer syndromes, with a particular focus on Lynch syndrome-associated gynecologic malignancies. Her work centers on improving early detection strategies for endometrial cancer in high-risk populations, where she has made significant contributions to understanding the efficacy of surveillance protocols. In her notable 2023 case report, Dr. Kanai demonstrated that endometrial cancer can be diagnosed at an early, treatable stage through rigorous annual transvaginal ultrasonography and endometrial biopsy in Lynch syndrome patients—a finding that reinforces the critical importance of adherence to screening guidelines for carriers of DNA mismatch repair gene mutations. While her research portfolio is still developing, with her most-cited work accumulating 2 citations, her clinical insights have immediate relevance for oncologists and genetic counselors managing hereditary cancer risk. Dr. Kanai's work bridges the gap between genetic predisposition and actionable surveillance strategies, offering hope for improved outcomes in this vulnerable patient population. Her ongoing research continues to refine risk-reduction approaches for individuals with Lynch syndrome.
Research Focus
Key Achievements
Top Papers
- 1